Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells

PURPOSE: Retinal pigment epithelial (RPE) cells play key roles in the development of choroidal neovascularization and subsequent fibrosis. We investigated the impact of bevacizumab, antihuman vascular endothelial growth factor (VEGF) antibody, and anticonnective tissue growth factor (anti-CTGF) neut...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Vis
Päätekijät: Bagheri, Abouzar, Soheili, Zahra-Soheila, Ahmadieh, Hamid, Samiei, Shahram, Sheibani, Nader, Astaneh, Shamila Darvishalipour, Kanavi, Mozhgan Rezaei, Mohammadian, Azam
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Molecular Vision 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4392827/
https://ncbi.nlm.nih.gov/pubmed/25883524
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia